Literature DB >> 11275359

Safety factor at the neuromuscular junction.

S J Wood1, C R Slater.   

Abstract

Reliable transmission of activity from nerve to muscle is necessary for the normal function of the body. The term 'safety factor' refers to the ability of neuromuscular transmission to remain effective under various physiological conditions and stresses. This is a result of the amount of transmitter released per nerve impulse being greater than that required to trigger an action potential in the muscle fibre. The safety factor is a measure of this excess of released transmitter. In this review we discuss the practical difficulties involved in estimating the safety factor in vitro. We then consider the factors that influence the safety factor in vivo. While presynaptic transmitter release may be modulated on a moment to moment basis, the postsynaptic features that determine the effect of released transmitter are not so readily altered to meet changing demands. Different strategies are used by different species to ensure reliable neuromuscular transmission. Some, like frogs, rely on releasing a large amount of transmitter while others, like man, rely on elaborate postsynaptic specialisations to enhance the response to transmitter. In normal adult mammals, the safety factor is generally 3-5. Both pre- and postsynaptic components change during development and may show plasticity in response to injury or disease. Thus, both acquired autoimmune and inherited congenital diseases of the neuromuscular junction (NMJ) can significantly reduce, or even transiently increase, safety factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275359     DOI: 10.1016/s0301-0082(00)00055-1

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  114 in total

1.  Sodium channel mRNAs at the neuromuscular junction: distinct patterns of accumulation and effects of muscle activity.

Authors:  S S Awad; R N Lightowlers; C Young; Z M Chrzanowska-Lightowlers; T Lomo; C R Slater
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

2.  Temperature effect on proximal to distal gradient of quantal release of acetylcholine at frog endplate.

Authors:  D Samigullin; E Bukharaeva; E Nikolsky; F Vyskocil
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

3.  Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.

Authors:  D Lashley; J Palace; S Jayawant; S Robb; D Beeson
Journal:  Neurology       Date:  2010-05-11       Impact factor: 9.910

4.  Recovery of electrogenesis in skeletal muscles after cell therapy of myodystrophy in MDX mice.

Authors:  V V Kravtsova; V M Mikhailov; A V Sokolova; E V Mikhailova; N A Timonina; E E Nikol'skii; I I Krivoi
Journal:  Dokl Biol Sci       Date:  2012-01-07

5.  Effects of diet on synaptic vesicle release in dynactin complex mutants: a mechanism for improved vitality during motor disease.

Authors:  Joel M Rawson; Tabita Kreko; Holly Davison; Rebekah Mahoney; Alex Bokov; Leo Chang; Jon Gelfond; Greg T Macleod; Benjamin A Eaton
Journal:  Aging Cell       Date:  2012-02-22       Impact factor: 9.304

6.  Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.

Authors:  Peter T Hallock; Chong-Feng Xu; Tae-Ju Park; Thomas A Neubert; Tom Curran; Steven J Burden
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

7.  The nicotinic acetylcholine receptor and the Na,K-ATPase alpha2 isoform interact to regulate membrane electrogenesis in skeletal muscle.

Authors:  Judith A Heiny; Violetta V Kravtsova; Frederic Mandel; Tatiana L Radzyukevich; Boubacar Benziane; Alexander V Prokofiev; Steen E Pedersen; Alexander V Chibalin; Igor I Krivoi
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

8.  Robust and accurate decoding of motoneuron behaviour and prediction of the resulting force output.

Authors:  Christopher K Thompson; Francesco Negro; Michael D Johnson; Matthew R Holmes; Laura Miller McPherson; Randall K Powers; Dario Farina; Charles J Heckman
Journal:  J Physiol       Date:  2018-06-09       Impact factor: 5.182

9.  Presynaptic mechanisms controlling calcium-triggered transmitter release at the neuromuscular junction.

Authors:  Markus Dittrich; Anne E Homan; Stephen D Meriney
Journal:  Curr Opin Physiol       Date:  2018-03-17

10.  Animal models of antimuscle-specific kinase myasthenia.

Authors:  David P Richman; Kayoko Nishi; Michael J Ferns; Joachim Schnier; Peter Pytel; Ricardo A Maselli; Mark A Agius
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.